SOLV
Solventum Corporation Healthcare - Medical Instruments & Supplies Investor Relations →
Solventum Corporation (SOLV) closed at $78.12 as of 2026-02-02, trading 11.5% above its 200-week moving average of $70.07. The stock moved further from the line this week, up from 10.0% last week. The 14-week RSI sits at 61, indicating neutral momentum.
Over the past 49 weeks of data, SOLV has crossed below its 200-week moving average 1 time. On average, these episodes lasted 4 weeks.
With a market cap of $13.5 billion, SOLV is a large-cap stock. The company generates a free cash flow yield of 4.3%. Return on equity stands at 37.3%, indicating strong profitability. The stock trades at 2.7x book value.
Over the past 1 years, a hypothetical investment of $100 in SOLV would have grown to $118, compared to $125 for the S&P 500. SOLV has returned 18.0% annualized vs 24.9% for the index, underperforming the broader market over this period.
Free cash flow has been declining at a -25.2% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Growth of $100: SOLV vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After SOLV Crosses Below the Line?
Each line shows $100 invested at the moment SOLV crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
SOLV has crossed below its 200-week MA 1 time
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Mar 2025 | Apr 2025 | 4 | 0.3% | N/A | +18.0% |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02